Skip to main content
Clinical Trials/NCT02275247
NCT02275247
Unknown
Not Applicable

Preventive Effect of Stellate Ganglion Block on Cerebral Vasospasm in Patients Undergoing Aneurysm Surgery

General Hospital of Ningxia Medical University1 site in 1 country40 target enrollmentAugust 2014

Overview

Phase
Not Applicable
Intervention
Stellate Ganglion Block
Conditions
Intracranial Aneurysm
Sponsor
General Hospital of Ningxia Medical University
Enrollment
40
Locations
1
Primary Endpoint
The incidence of cerebral vasospasm
Last Updated
9 years ago

Overview

Brief Summary

To investigate whether stellate ganglion block is helpful to brain protection during cranial aneurysm surgery

Detailed Description

The vasospasm after cranial aneurysm surgery have a higher incidence, but not have an ideal treatment method. At present, the medical treatment is very limited effect to prevent the perioperative cerebral ischemia.Stellate ganglion block (SGB)is an effective and well-tolerated approach to the treatment of CVS in various clinical settings.Resent study indicated that SGB has a protective effect on delayed cerebral vasospasm in an experimental rat model of subarachnoid hemorrhage.Therefore,we hypothesized that the preoperative SGB would be a effective treatment for improvement of vasospasm after cranial aneurysm surgery.

Registry
clinicaltrials.gov
Start Date
August 2014
End Date
October 2016
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
General Hospital of Ningxia Medical University
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • aneurysm subarachnoid hemorrhage patients scheduled for cranial aneurysm surgery,
  • ASA grade:Ⅱ-Ⅲ,
  • Hunt~Hess grade :Ⅰ-Ⅲ,
  • have a informed consent.

Exclusion Criteria

  • history of mental illness,
  • local infection who can't do stellate ganglion block,
  • pregnant or lactating,
  • nausea cancer or diabetes,
  • participated the study or other related research in the last 30 days,
  • unruptured aneurysms patients

Arms & Interventions

Intervention 'Stellate Ganglion Block'

Experimental patients will receive a stellate ganglion block with 0.25% ropivacaine 6-8mL on the right side at the level of the sixth cervical vertebrae (C6) before surgery.Then the catheter will be attached to a single use patient-controlled analgesia pump containing 0.2% ropivacaine 150 mL, which will be infused at 2 mL/h.

Intervention: Stellate Ganglion Block

Outcomes

Primary Outcomes

The incidence of cerebral vasospasm

Time Frame: Change from baseline at 2hour,6hour,1day,3day,and 7day after aneurysm surgery

The occurrence of cerebral vasospasm will be diagnosed by using of the transcranial doppler instrument.

Secondary Outcomes

  • Perioperative cerebral oxygen metabolism(Change from baseline at 2hour,6hour,1day,3day,and 7day postoperatively)
  • The difference of plasma endothelin, melatonin, and S100-β protein level between two groups at each time point(Change from baseline at 2hour,6hour,1day,3day,and 7day postoperatively)
  • Postoperative cognitive function(Change from baseline at 2hour,6hour,1day,3day,and 7day after aneurysm surgery)

Study Sites (1)

Loading locations...

Similar Trials